Pain Medicine, Interventional Pain Medicine · Louisville, KY
NPI
1720494537
Since 2014
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11300 Maple Brook Dr
Louisville, KY, 40241
Phone (502) 253-0505
Groups this clinician bills Medicare through
Medicare paid, 2024
$516K
7,202 services
Medicare patients, 2024
568
Average age 68
Drug cost, 2024
$890K
18,121 prescriptions
Company payments, 2025
$1,846
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nathan Lamborn was code 99213 (office e&m - established), 1,541 times for 426 patients. In total Nathan Lamborn billed 7,202 services in 49 codes, and Medicare paid $516K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,541 | 426 | $66.16 | $102K |
| 99214 Office E&M - Established | Office | 1,364 | 458 | $98.73 | $135K |
| 80307 Drug Tests | Office | 1,359 | 487 | $60.82 | $83K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 1,052 | 220 | $5.42 | $5,697 |
| 99212 Office E&M - Established | Office | 508 | 252 | $33.90 | $17K |
| 99211 Office E&M - Established | Office | 163 | 151 | $16.16 | $2,635 |
| 62323 Nerve Block Injection - Back | Office | 156 | 104 | $193.91 | $30K |
| G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 153 | 153 | $27.06 | $4,140 |
| 99204 Office E&M - New | Office | 151 | 151 | $127.97 | $19K |
| 20610 Joint Injection | Office | 94 | 62 | $57.54 | $5,408 |
| 77002 Imaging - Miscellaneous | Office | 91 | 61 | $83.16 | $7,567 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 53 | 42 | $483.89 | $26K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 53 | 42 | $264.28 | $14K |
| 99406 Behavioral Health Services | Office | 44 | 41 | $14.69 | $646 |
| 64493 Nerve Block Injection - Back | Office | 38 | 21 | $198.77 | $7,553 |
By year: 2022 $443K for 7,725 services; 2023 $415K for 7,416 services; 2024 $516K for 7,202 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 1,359 | 487 | $60.82 | $83K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 28 | 20 | $29.40 | $823 |
Medicare prescription drug claims, 2024
In 2024, the drug Nathan Lamborn prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 5,394 prescriptions and refills. In total Nathan Lamborn wrote 18,121 Medicare prescriptions that cost $890K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 5,394 | 5,400 | 640 | $125K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,812 | 3,819 | 481 | $123K |
| Gabapentin Generic | 2,949 | 3,209 | 462 | $35K |
| Pregabalin Generic | 589 | 678 | 107 | $19K |
| Oxycodone Hcl Generic | 561 | 561 | 105 | $21K |
| Tizanidine Hcl Generic | 543 | 677 | 113 | $6,922 |
| Tramadol Hcl Generic | 520 | 524 | 81 | $5,255 |
| Cyclobenzaprine Hcl Generic | 439 | 477 | 94 | $1,827 |
| Naloxone Hcl Generic | 406 | 406 | 404 | $21K |
| Baclofen Generic | 351 | 390 | 87 | $4,760 |
| Methadone Hcl Generic | 325 | 325 | 48 | $10K |
| Diazepam Generic | 273 | 274 | 142 | $237 |
| Meloxicam Generic | 162 | 185 | 62 | $503 |
| Amitriptyline Hcl Generic | 153 | 217 | 36 | $1,522 |
| Methocarbamol Generic | 140 | 148 | 26 | $1,274 |
Brand drugs: 421 claims; generic drugs: 17,700 claims; opioid claims: 11,323.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nathan Lamborn $1,846 ($1,846 in general payments such as food, travel and fees) from 6 companies. The largest payer was Medtronic, Inc. with $1,189.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.